- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Atopic dermatitis
- Meeting Date: July 2019
- Public Summary Document (PSD) July 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) July 2019 PBAC Meeting - (Word 181KB)
Dupilumab – July 2019
Dupilumab: Injection 300 mg in 2 mL single use pre-filled syringe; Dupixent®
Last updated
1 November 2019